PHGDH and neuroblastoma: These results indicate that the flow of glucose metabolism was switched from the direction of serine biosynthesis pathway to the downstream direction of glycolytic system, indicating that PHGDH inhibitors induce metabolic changes in neuroblastoma similar to those previously reported for other malignancies.